CAS: 1386874-06-1
![2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)...](https://static.cymitquimica.com/products/IN/thumb/DA001900.jpg)
2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methyl-
CAS:1386874-06-1
Fórmula:
C23H26N4O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
406.4775
Ref: IN-DA001900
| 10mg | 149,00 € | ||
| 25mg | 293,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Samotolisib
CAS:1386874-06-1
Samotolisib (LY3023414) inhibits PI3K, DNA-PK, mTOR; tested for solid tumors including breast and colon cancer.
Fórmula:
C23H26N4O3
Pureza:
98.41% - 99.69%
Forma y color:
Solid
Peso molecular:
406.48
Ref: TM-T6883
| 5mg | 48,00 € | ||
| 10mg | 75,00 € | ||
| 25mg | 149,00 € | ||
| 50mg | 250,00 € | ||
| 100mg | 368,00 € | ||
| 200mg | 523,00 € | ||
| 1mL*10mM (DMSO) | 51,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
Samotolisib
CAS:1386874-06-1
Samotolisib is a novel drug that has been shown to inhibit tumor growth in vivo. …
Fórmula:
C23H26N4O3
Pureza:
Min. 95%
Peso molecular:
406.48 g/mol
Ref: 3D-LFC87406
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
